In vivo antitumoral activity of Larrea divaricata

C ANESINI; A GENARO; GA CREMASCHI; M ZUBILLAGA; J BOCCIO; L STERIN-BORDA; E BORDA

ACTA PHYSIOL PHARMACOL THER LATINOAM

Asociación Latinoamericana de Ciencias Fisiológicas

Lugar: Argentina; Año: 1996 vol. 46 p. 33 - 40

0327-6309

We previously reported that aqueous extract of Larrea divaricata Cav. had an antiproliferative activity upon tumoral lymphoid cells (BW 5147), without affecting normal immunity. To determine the probable mechanism of the inhibitory action of the extract upon cell growth, the participation of intracellular signals involved in the inhibition of cell proliferation, namely the activation of adenylate cyclase system was studied. The production of cyclic 3´, 5 adenosine monophosphate (cAMP) in presence and absence of extract was analized. The extract increased the cAMP levels, but neither the cAMP production nor the inhibitory effect of the extract on proliferation were blocked by a beta adrenergic receptor antagonist (propranolol) or by histaminergic receptor antagonists (cimetidine and mepyramine). So, we concluded that the antiproliferative activity of the extract of BW 5147 cells would be mediated by an increase in cAMP intracellular levels no related to the activation of the membrane receptors here studied. In parallel, the extract was administered to a pregnant rat with a spontaneous mammarian carcinoma and "in vivo" antitumoral activity was found.